EUVIMEDEUVIMED entdecken
Crossref

Epigenome editing in cancer: Advances and challenges for potential therapeutic options

Seung-Won Lee, Connor Mitchell Frankston, Jungsun Kim

International Review of Cell and Molecular Biology · 2024 · 191-230

DOI: 10.1016/bs.ircmb.2023.10.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Review of Cell and Molecular Biology, 2024. Verfasst von Seung-Won Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Department…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 326 Literaturangaben. Gefördert von: Knight Cancer Institute, Oregon Health and Science University, Misophonia Research Fund, Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNeoplasmsHumansEpigenomeEpigenesis, GeneticGene EditingOncogenesDNA Methylation

Stichwörter der Autor:innen

Epigenetic alterationsEpigenetic therapeutic optionsEpigenome editing

Autor:innen und Institutionen

  • Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Department of Molecular and Medical Genetics, School of Medicine, Oregon Health…
  • Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States; Biomedical Engineering Graduate Program, Department of Biomedical Engineering, S…

Förderung

  • Knight Cancer Institute, Oregon Health and Science University
  • Misophonia Research Fund
  • Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University

Zitieren

APA

Lee, S. W., Frankston, C. M., & Kim, J. (2024). Epigenome editing in cancer: Advances and challenges for potential therapeutic options. International Review of Cell and Molecular Biology, 191-230. https://doi.org/10.1016/bs.ircmb.2023.10.001

Vancouver

Lee SW, Frankston CM, Kim J. Epigenome editing in cancer: Advances and challenges for potential therapeutic options. International Review of Cell and Molecular Biology. 2024:191-230. doi:10.1016/bs.ircmb.2023.10.001

BibTeX
@article{Lee2024,
  author = {Lee, Seung-Won and Frankston, Connor Mitchell and Kim, Jungsun},
  title = {Epigenome editing in cancer: Advances and challenges for potential therapeutic options},
  journal = {International Review of Cell and Molecular Biology},
  year = {2024},
  pages = {191--230},
  doi = {10.1016/bs.ircmb.2023.10.001}
}
Kostenlos starten →